Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Nanomedicine platforms can be designed to selectively target MDSCs based on their surface receptor expression or metabolic vulnerabilities, thereby reducing systemic immunosuppression while preserving beneficial myeloid populations (32, 33)
15.9% with
Blood 122, 2013
Atorvastatin acts synergistically with N-acetyl cysteine to provide therapeutic advantage against Fas-activated erythrocyte apoptosis during chronic arsenic exposure in rats
Kuwait faces one of the highest burdens of CKM-related diseases globally
US$ 23.72
US$ 22.77
US$ 23.47
US$ 24.59
US$ 28.12
US$ 23.79
